MarketCapExport financials
Aethlon Medical (AEMD)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Aethlon Medical Income Statement 2026-2010 | AEMD
Brief overview of financial performance at Aethlon Medical
The figures are compared over a five-year interval. The revenue attributed to Aethlon Medical moved from $150 thousand to $574 thousand between the two endpoints. The total change was +283.8%, with a CAGR of approximately 30.9%. This pace points to rapid expansion of the business.
The gross result shifted from −2.5 million dollars to −3.9 million dollars, or −55.7%. The cost base moved more slowly than the top line, which supported margins. Comparing the endpoints gives gross margins of −1661% and −673.8%. The margin shift points to a more favorable sales-and-cost structure.
The operating result measured by EBITDA moved from −4.8 million dollars to −11.7 million dollars, or −143.1%. The operating result developed less favorably than sales. EBITDA margin moved from −3205% to −2030.1%. Higher profitability strengthens the quality of operating growth.
Net income moved from −$5.7 million at the start to −$12 million at the end. The loss widened and increased the financial risk.
Over the period, capitalization shifted from 16.5 million dollars to 863 thousand dollars (−94.8%). Capitalization lags the underlying business improvement.
Conclusion
The results contain several connected negative signals. The constructive conclusion rests on better sales economics, a larger revenue base and higher operating efficiency. The overall view is constrained by declining net profitability, lower investor confidence and limited operating profitability. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement Aethlon Medical
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.36 M | 303 K | 182 K | 863 K | 6.2 M | 12.1 M | 4.78 M | 13.8 M | 16.5 M | 17.3 M | 35.9 M | 45.6 M | 40.8 M | 16.4 M | 11.2 M | 6.26 M | - |
Shares |
674 K | 156 K | 314 K | 2.05 M | 14.8 M | 12.1 M | 3.41 M | 1.21 M | 821 K | 518 K | 493 K | 373 K | 259 K | 199 K | 136 K | 92.8 K | - |
Historical Prices |
2.02 | 1.94 | 0.58 | 0.42 | 0.42 | 1.32 | 2.2 | 2.73 | 14.7 | 22.6 | 56.5 | 72.2 | 142 | 128 | 67.5 | 90 | - |
Net Income |
-7.15 M | -13.4 M | -12.2 M | -12 M | -10.4 M | -7.89 M | -6.37 M | -6.19 M | -5.68 M | -7.28 M | -4.87 M | -6.8 M | -13.4 M | -4.89 M | -8.11 M | -5.71 M | - |
Revenue |
- | - | - | 574 K | 294 K | 659 K | 650 K | 230 K | 150 K | 392 K | 887 K | 762 K | 1.62 M | 1.23 M | 1.36 M | - | - |
Cost of Revenue |
2.79 M | 3.87 M | 5.21 M | 4.44 M | 4.63 M | 3.45 M | 2.3 M | 3.08 M | 2.63 M | 3.48 M | 2.08 M | 2.28 M | 2.23 M | 2.17 M | 2.05 M | 2.9 M | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.36 M | - | - |
Operating Income |
-7.29 M | -9.34 M | -12.6 M | -11.9 M | -10.4 M | -7.89 M | -5.93 M | -6 M | -4.83 M | -6.1 M | -4.38 M | -3.99 M | -3.06 M | -3.58 M | -3.11 M | -4.56 M | - |
Interest Expense |
- | 10.1 K | - | - | - | - | - | - | - | - | - | 350 K | 1.29 M | - | - | - | - |
EBITDA |
-6.97 M | -9 M | -12.3 M | -11.7 M | -10.3 M | -7.85 M | -5.9 M | -5.97 M | -4.8 M | -6.07 M | -4.35 M | -3.96 M | -3.03 M | -3.56 M | -3.1 M | -4.54 M | - |
Operating Expenses |
7.29 M | 9.34 M | 12.6 M | 12.5 M | 10.7 M | 8.55 M | 6.58 M | 6.23 M | 4.98 M | 6.49 M | 5.27 M | 4.76 M | 4.68 M | 4.81 M | 4.47 M | 4.56 M | - |
General and Administrative Expenses |
2.7 M | 3.24 M | 3.9 M | 4.48 M | 3.46 M | 2.46 M | 6.58 M | 6.23 M | 4.98 M | 6.49 M | 5.27 M | 4.76 M | 4.68 M | 4.81 M | 4.47 M | 4.56 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Aethlon Medical
| 2027-Q1 | 2026-Q4 | 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
41.5 K | - | 823 K | 398 K | 2.08 M | 823 K | 398 K | 2.08 M | 201 K | 175 K | 174 K | 932 K | 2.63 M | 2.52 M | 2.48 M | 2.43 M | 2.3 M | 2.29 M | 2.07 M | 15.5 M | 15.4 M | 15.4 M | 14.5 M | 14.1 M | 15.4 M | 12.1 M | 12.1 M | 12.1 M | 9.63 M | 2.89 M | 2.89 M | 1.32 M | 19.1 M | 1.2 M | 18.1 M | 17.8 M | 17.7 M | 15 M | 9.03 M | 8.81 M | 8.8 M | 7.93 M | 7.77 M | 7.69 M | 7.62 M | 7.62 M | 7.32 M | 7.17 M | 6.66 M | 6.03 M | 259 M | 227 M | 4.5 M | 198 M | 188 M | 182 M | 174 M | 159 M | 143 M | 135 M | 118 M | 107 M | 98.2 M | 93.8 M | 77.5 M |
Net Income |
-1.76 M | - | -2.02 M | -1.49 M | -1.76 M | -2.02 M | -1.49 M | -1.76 M | - | -1.75 M | -2.81 M | -2.57 M | - | -3.47 M | -3.03 M | -3.28 M | - | -2.85 M | -3.81 M | -2.91 M | - | -2.53 M | -6.63 M | -2.1 M | - | -2.44 M | -5.62 M | -1.77 M | -1.41 M | -820 K | -820 K | -1.71 M | -2.07 M | -2.01 M | -2.01 M | -1.39 M | - | -1.22 M | -1.3 M | -1.84 M | - | -1.21 M | -5.59 M | -4.38 M | - | -1.22 M | -3.62 M | -2.41 M | - | -1.55 M | -5.91 M | -4.5 M | - | -2.23 M | -5.88 M | -3.65 M | - | 314 K | -2.13 M | -2.44 M | - | -575 K | -3.61 M | -3.04 M | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.1 K | 281 K | 264 K | - | 625 K | 625 K | - | - | 413 K | 413 K | - | 30 K | - | - | - | - | 74.8 K | - | - | - | - | 392 K | 4.64 K | - | - | - | - | - | 33.4 K | 479 K | 51.3 K | - | 76.3 K | 917 K | 840 K | - | 209 K | 826 K | 617 K | - | 958 K | 958 K | - | - |
Cost of Revenue |
581 K | - | 987 K | 595 K | 581 K | 987 K | 595 K | 581 K | - | 620 K | 1.37 M | 1.25 M | - | 1.92 M | 1.19 M | 1.12 M | - | 1.05 M | 1.11 M | 1.03 M | - | 1 M | 2.82 M | 1.82 M | - | 1.52 M | 1.52 M | 560 K | 437 K | 406 K | 406 K | 598 K | 606 K | 1.16 M | 1.16 M | 672 K | - | 663 K | 618 K | 630 K | - | 636 K | 2.79 M | 2.16 M | - | 615 K | 1.67 M | 1.06 M | - | 571 K | 1.74 M | 1.17 M | - | 425 K | 1.29 M | 863 K | - | 507 K | 1.62 M | 1.11 M | - | 488 K | 1.55 M | 1.07 M | - |
Operating Income |
-1.79 M | - | -2.06 M | -1.51 M | -1.79 M | -2.06 M | -1.51 M | -1.79 M | - | -1.81 M | -2.9 M | -2.62 M | - | -3.57 M | -3.18 M | -3.41 M | - | -2.85 M | -3.67 M | -2.91 M | - | -2.53 M | -6.64 M | -4.11 M | - | -2.44 M | -2.44 M | -1.77 M | -1.41 M | -876 K | -876 K | -1.7 M | -1.57 M | -1.96 M | -1.96 M | -1.35 M | - | -1.16 M | -1.24 M | -1.16 M | - | -1.24 M | -4.59 M | -3.36 M | - | -1.08 M | -3.3 M | -2.21 M | - | -1.09 M | -2.86 M | -1.77 M | - | -1.23 M | -2.25 M | -1.01 M | - | -937 K | -2.73 M | -1.79 M | - | -341 K | -2.26 M | -1.92 M | - |
Interest Expense |
30.5 K | - | 43.9 K | 22.7 K | -5.93 K | 43.9 K | 22.7 K | -5.93 K | - | 60 K | 95.1 K | - | - | - | - | - | - | - | - | - | - | - | - | 125 | - | - | - | 728 | - | - | 54 K | 54 K | - | - | - | - | - | - | - | 189 K | - | - | 113 K | 77.4 K | - | - | 400 K | 252 K | - | - | - | 78.7 K | - | - | 330 K | 217 K | - | - | - | 25 K | - | - | 360 K | 360 K | - |
EBITDA |
-1.71 M | - | -1.82 M | -1.35 M | -1.71 M | - | - | -1.71 M | - | - | - | -2.53 M | - | - | - | -3.32 M | - | -2.85 M | -3.5 M | -2.88 M | - | -2.53 M | -6.54 M | -4.03 M | - | -2.44 M | -2.41 M | -1.75 M | -1.4 M | -876 K | -860 K | -1.7 M | -1.56 M | -1.96 M | -1.94 M | -1.33 M | - | -1.16 M | -1.24 M | -1.15 M | - | -1.24 M | -4.57 M | -3.34 M | - | -1.08 M | -3.27 M | -2.2 M | - | -1.09 M | -2.83 M | -1.76 M | - | -1.23 M | -2.23 M | -1.01 M | - | -937 K | -2.72 M | -1.79 M | - | -341 K | -2.24 M | -1.91 M | - |
Operating Expenses |
1.79 M | - | 2.06 M | 1.51 M | 1.79 M | 2.06 M | 1.51 M | 1.79 M | - | 1.81 M | 2.9 M | 2.62 M | - | 3.57 M | 3.18 M | 3.41 M | - | 2.85 M | 3.67 M | 2.91 M | - | 2.55 M | 6.92 M | 4.37 M | - | 3.07 M | 3.07 M | 1.77 M | 1.41 M | 1.29 M | 1.29 M | 1.7 M | 1.6 M | 1.96 M | 1.96 M | 1.35 M | - | 1.24 M | 1.24 M | 1.16 M | - | 1.24 M | 4.99 M | 3.75 M | - | 1.39 M | 3.98 M | 2.6 M | - | 1.12 M | 3.42 M | 2.3 M | - | 1.31 M | 3.16 M | 1.85 M | - | 1.15 M | 3.55 M | 2.41 M | - | 1.3 M | 3.21 M | 1.92 M | - |
General and Administrative Expenses |
735 K | - | 218 K | 218 K | 735 K | 742 K | 521 K | 735 K | - | 816 K | 958 K | 752 K | - | 979 K | 851 K | 1.31 M | - | 1.07 M | 1.55 M | 1.03 M | - | 1.11 M | 2.43 M | 1.32 M | - | 921 K | 920 K | 555 K | 409 K | 274 K | 274 K | 342 K | 383 K | 215 K | 215 K | 272 K | - | 136 K | 235 K | 187 K | - | 183 K | 697 K | 514 K | - | 383 K | 994 K | 612 K | - | 467 K | 896 K | 428 K | - | 330 K | 669 K | 339 K | - | 196 K | 563 K | 367 K | - | 384 K | 624 K | 240 K | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Aethlon Medical (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Britain
Curacao
Israel
Australia
France
